Clinical Trial Update: Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update covers a Phase 1/2 study of recombinant human hyaluronidase for lymphedema in cancer patients. The trial was terminated and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lymphedema

Drugs mentioned

• Hylenex (hyaluronidase)

Snippet

Sponsor: Stanford University | Conditions: Lymphedema, Malignant Neoplasm | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-02-07